Grace Therapeutics, Inc. (GRCE) Net margin 2022–2023
Grace Therapeutics, Inc. (GRCE) net profit margin by fiscal year — reported net income divided by reported revenue.
-42.4%FY2023 · since FY2022: -5009.7% → -42.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -42.4% | +4967.3 pp |
| FY2022 | -5009.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice